Deramiocel has the potential to become the first therapy to address both skeletal and cardiac manifestations of Duchenne muscular dystrophyBLA supported by positive pivotal HOPE-3 Phase 3 results, ...

NMD Pharma will also present an update on the ongoing SYNAPSE-MG Phase 2b clinical trial of ignaseclant in generalized myasthenia gravis Aarhus, Denmark, 10 March 2026 – NMD Pharma A/S, a ...

A supercomputer predicted the outcome of the UEFA Champions League Round of 16 first leg between Real Madrid and Manchester ...

New research debunks the old myth that masturbation or orgasm reduces athletic performance or testosterone levels.